20th March 2025 by Dr Louise Hudman
NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.
This guidance was published in March 2025.
It is the very snappily named ’12 SQ-HDM SLIT’. Its trade name is ACARIZAX.
Immunotherapy (Acarizax) for dust mite allergy and allergic rhinitis
NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.
Thrombophilia testing (2022)
This is a guideline from the British Society of Haematology on when to test for thrombophilia, published in May 2022.
Palforzia for peanut allergy in children and young people
The idea of Palforzia treatment is for patients to be able to tolerate small amounts of peanuts in their diet.
"LocumDeck has been fabulous: easy, simple and practical one-stop shop. For both GP locums and practices, my experience is it works really well"
Dr Peter Weeks, GP locum, Lancashire